November 25, 2021
According to the research report titled, ‘Global Advanced Clinical Decision Support Platforms Market by Type (Therapeutic and Diagnostic), Model (Knowledge based, and non-Knowledge based), and Setting (Hospitals and Ambulatory care), Regional Forecasts 2021-2027’, available with MarketStudyReport, global advanced clinical decision support platform market was worth USD 1.2 billion in 2020 and is anticipated to register an annual growth rate of 9.1% over 2021-2027, thereby accumulating USD 22 billion by the end of the forecast duration.
Rapid surge in geriatric population, rising number of chronic diseases and increasing occurrences of medication errors are the major factors aiding towards the expansion of global advanced clinical decision support platforms market.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4285256/
For the unversed, clinic decision support system (CDSS) is a computer-based application which assesses data stored in electronic health record (EHRS) and provides suggestions to help healthcare professionals abide by evidence-based clinical standards during treatment procedures.
In addition, increasing number of deaths and disabilities due to chronic diseases is augmenting industry outlook. As per American Cancer Society, lung cancer was the cause behind at least 1.8 million deaths globally in 2020.
On the contrary, surging concerns associated with patient data and safety are likely to hamper the remuneration scope of the marketplace in the ensuing years.
Based on type, global advanced clinical decision support platforms market is split into therapeutic and diagnostic, whereas fragmented in terms of model includes knowledge based and non-knowledge based. Further, with respect to setting the industry is classified into hospitals and ambulatory care.
Considering the geographical ambit, North America, Europe, Asia Pacific, and Latin America are the major benefactors to the market remuneration. Among these, Asia Pacific market is projected to expand significantly during 2021-2027 owing to growing aging population, favorable government regulations and rising prevalence of chronic diseases.
Moreover, major market participants are increasing their focus to tap into emerging markets in the region, which in turn is propelling the market progression in Asia-Pacific.
Key players operating in global advanced clinical decision support platforms market are GE Healthcare, Siemens Healthineers AG, Athenahealth Inc., NextGen Healthcare Inc., Zynx Health Incorporated, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Wolters Kluwer N.V., and Philips Healthcare.